Vincenzo Accurso

701 total citations
30 papers, 329 citations indexed

About

Vincenzo Accurso is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Vincenzo Accurso has authored 30 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Hematology and 9 papers in Rheumatology. Recurrent topics in Vincenzo Accurso's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Eosinophilic Disorders and Syndromes (9 papers). Vincenzo Accurso is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Eosinophilic Disorders and Syndromes (9 papers). Vincenzo Accurso collaborates with scholars based in Italy, Argentina and Spain. Vincenzo Accurso's co-authors include Salvatrice Mancuso, Sergio Siragusa, Vincenzo Abbadessa, Giuseppina Campisi, Valerio Margiotta, Marco Santoro, Antonio Russo, Giuseppina Novo, Simona Raso and Alessandro Perez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Vincenzo Accurso

29 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincenzo Accurso Italy 11 129 107 90 79 75 30 329
Ambra Di Veroli Italy 13 118 0.9× 228 2.1× 72 0.8× 3 0.0× 40 0.5× 31 340
Alexander Marsland United Kingdom 15 180 1.4× 37 0.3× 22 0.2× 5 0.1× 35 0.5× 29 648
Hideyuki Takamatsu Japan 7 39 0.3× 206 1.9× 10 0.1× 2 0.0× 56 0.7× 13 371
Léonardo Magro France 11 116 0.9× 270 2.5× 37 0.4× 2 0.0× 119 1.6× 43 469
Gottfried Doelken Germany 8 68 0.5× 42 0.4× 28 0.3× 4 0.1× 174 2.3× 15 296
Kazuho Shimura Japan 10 43 0.3× 91 0.9× 13 0.1× 4 0.1× 123 1.6× 34 328
Shinichiro Machida Japan 8 60 0.5× 151 1.4× 48 0.5× 2 0.0× 74 1.0× 39 258
Gail Abrahamson United Kingdom 9 63 0.5× 260 2.4× 33 0.4× 2 0.0× 87 1.2× 13 346
Ruxandra Ionescu Romania 10 21 0.2× 40 0.4× 35 0.4× 4 0.1× 15 0.2× 38 302
José Miguel Couselo Spain 9 59 0.5× 118 1.1× 83 0.9× 1 0.0× 27 0.4× 13 332

Countries citing papers authored by Vincenzo Accurso

Since Specialization
Citations

This map shows the geographic impact of Vincenzo Accurso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenzo Accurso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenzo Accurso more than expected).

Fields of papers citing papers by Vincenzo Accurso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincenzo Accurso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenzo Accurso. The network helps show where Vincenzo Accurso may publish in the future.

Co-authorship network of co-authors of Vincenzo Accurso

This figure shows the co-authorship network connecting the top 25 collaborators of Vincenzo Accurso. A scholar is included among the top collaborators of Vincenzo Accurso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincenzo Accurso. Vincenzo Accurso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gisslinger, Heinz, Valerio De Stefano, Vincenzo Accurso, et al.. (2023). Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study. European Journal Of Haematology. 112(3). 379–391. 1 indexed citations
2.
Rovetta, Alessandro, et al.. (2023). An Improved Peer-Review System to Compensate for Scientific Misconduct in Health-Sensitive Topics. Public health reviews. 44. 1605601–1605601. 1 indexed citations
3.
Santoro, Marco, Salvatrice Mancuso, Vincenzo Accurso, et al.. (2021). Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review. Frontiers in Physiology. 12. 675811–675811. 20 indexed citations
4.
Raso, Simona, Mariasanta Napolitano, Giulia Arrigo, et al.. (2021). Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis. Annals of Hematology. 100(3). 653–659. 3 indexed citations
5.
6.
Accurso, Vincenzo, Marco Santoro, Salvatrice Mancuso, et al.. (2020). CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020008–e2020008. 12 indexed citations
7.
Novo, Giuseppina, Daniela Di Lisi, Enrico Bronte, et al.. (2020). Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience. Oncology. 98(7). 445–451. 25 indexed citations
8.
Mancuso, Salvatrice, Marco Santoro, Vincenzo Accurso, et al.. (2020). Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?. Oncology Research and Treatment. 43(10). 526–530. 14 indexed citations
9.
Mancuso, Salvatrice, Vincenzo Accurso, Marco Santoro, et al.. (2020). The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors. Advances in Hematology. 2020. 1–5. 9 indexed citations
10.
Santoro, Marco, Vincenzo Accurso, Salvatrice Mancuso, et al.. (2019). Comparison between thrombotic risk scores in essential thrombocythemia and survival implications. Hematological Oncology. 37(4). 434–437. 10 indexed citations
11.
Accurso, Vincenzo, Marco Santoro, Salvatrice Mancuso, et al.. (2019). Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system. Drugs in Context. 8. 1–4.
12.
Accurso, Vincenzo, Marco Santoro, Simona Raso, et al.. (2019). Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study. SHILAP Revista de lepidopterología. 11(4). 8281–8281. 18 indexed citations
13.
Santoro, Marco, Vincenzo Accurso, Salvatrice Mancuso, et al.. (2019). Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors. Chemotherapy. 64(4). 205–209. 11 indexed citations
14.
Stella, Stefania, Michele Massimino, Elena Tirrò, et al.. (2019). Detection and Clinical Implications of a Novel BCR-ABL1 E12A2 Insertion/Deletion in a CML Patient Expressing the E13A2 Isoform. Anticancer Research. 39(12). 6965–6971. 9 indexed citations
15.
Luciano, Luigia, Giorgina Specchia, Bruno Martino, et al.. (2017). A Real Life Evaluation of Efficacy and Safety of Ponatinib Therapy in CML Patients. Blood. 130. 2905–2905. 4 indexed citations
16.
Napolitano, Mariasanta, Marco Santoro, Salvatrice Mancuso, et al.. (2017). Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate. Clinical Case Reports. 5(10). 1573–1575. 4 indexed citations
17.
Morabito, Alessandro, Gianfranco Filippelli, S. Palmeri, et al.. (2003). The Combination of Gemcitabine and Vinorelbine is an Active Regimen as Second-Line Therapy in Patients with Metastatic Breast Cancer Pretreated with Taxanes and/or Anthracyclines: a Phase I–II Study. Breast Cancer Research and Treatment. 78(1). 29–36. 21 indexed citations
18.
Palmeri, S., V. Leonardi, Manuela Tamburo De Bella, et al.. (2002). Doxorubicin-Docetaxel Sequential Schedule: Results of Front-Line Treatment in Advanced Breast Cancer. Oncology. 63(3). 205–212. 8 indexed citations
19.
Palmeri, S., V. Leonardi, Vittorio Gebbia, et al.. (2001). Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial. Lung Cancer. 34(1). 115–123. 15 indexed citations
20.
Margiotta, Valerio, Giuseppina Campisi, Salvatrice Mancuso, Vincenzo Accurso, & Vincenzo Abbadessa. (1999). HIV infection: oral lesions, CD4 + cell count and viral load in an ltalian study population. Journal of Oral Pathology and Medicine. 28(4). 173–177. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ambra Di Veroli Breakdown of academic impact, for papers by Alexander Marsland Breakdown of academic impact, for papers by Hideyuki Takamatsu Breakdown of academic impact, for papers by Léonardo Magro Breakdown of academic impact, for papers by Gottfried Doelken Breakdown of academic impact, for papers by Kazuho Shimura Breakdown of academic impact, for papers by Shinichiro Machida Breakdown of academic impact, for papers by Gail Abrahamson Breakdown of academic impact, for papers by Ruxandra Ionescu Breakdown of academic impact, for papers by José Miguel Couselo
Rankless by CCL
2026